List of works - Alfredo Berruti

5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma

scientific article published on 04 January 2016

A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy.

scientific article

Adjunctive treatment of adrenocortical carcinoma

scientific article published on June 2008

Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?

scientific article

Adjuvant mitotane treatment for adrenocortical carcinoma

scientific article

Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria

scientific article published on 28 May 2020

Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior

scientific article published on July 2010

Androgen deprivation modulates gene expression profile along prostate cancer progression.

scientific article published on 21 June 2016

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients

scientific article published on 3 August 2010

Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study

scientific article published on 14 September 2016

Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy

scientific article

Background to and management of treatment-related bone loss in prostate cancer.

scientific article

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study

scientific article

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.

scientific article published on May 2015

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

scientific article

Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy

scientific article

Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.

scientific article

Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease.

scientific article

Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.

scientific article published on 28 March 2011

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma

scientific article published on 15 August 2017

Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance

scientific article

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

scientific article

Combination chemotherapy in advanced adrenocortical carcinoma

scientific article published on 2 May 2012

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients

scientific article published in January 2005

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network

scientific article

Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?

scientific article published in April 2008

Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells

scientific article published on 09 April 2020

Decreasing Frequency of Osteonecrosis of the Jaw in Cancer and Myeloma Patients Treated with Bisphosphonates: The Experience of the Oncology Network of Piedmont and Aosta Valley (North-Western Italy) ⬇️

scientific article published on February 27, 2013

Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas

scientific article published on 26 March 2018

Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer

scientific article published on May 2008

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

scientific article published on 23 October 2017

Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review

scientific article published on 10 December 2018

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial

scientific article published in September 2005

Excess of second tumors in denosumab-treated patients: a metabolic hypothesis

scientific article published on 25 June 2019

Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases

scientific article published in March 2011

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients

scientific article

Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference.

scientific article published on 04 July 2015

Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients

scientific article

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

scientific article

Gene expression profiling in breast cancer: a clinical perspective.

scientific article published on 23 February 2013

Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma

scientific article published on 15 March 2018

Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells.

scientific article published on 08 May 2013

Human ASH1 expression in prostate cancer with neuroendocrine differentiation

scientific article

Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study

scientific article published on 14 April 2020

Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients

scientific article published in February 2009

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

scientific article published on May 2015

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

scientific article published on January 2011

Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.

scientific article

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

scientific article

Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.

scientific article published on 11 January 2017

Magnetic resonance imaging in comparison to clinical palpation in assessing the response of breast cancer to epirubicin primary chemotherapy.

scientific article published in June 2004

Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.

scientific article

Metronomic therapy concepts in the management of adrenocortical carcinoma

scientific article published on December 2011

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

scientific article

Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up

scientific article published in January 2005

Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.

scientific article published on 12 August 2015

Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.

scientific article published on 11 March 2016

Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies

scientific article

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma

scientific article

Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer

scientific article published on 8 December 2008

Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions.

scientific article

Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features ⬇️

scientific article published on November 16, 2010

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle

scientific article

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.

scientific article

Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review

scientific article

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

scientific article published on 29 September 2008

Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.

scientific article published on 30 July 2011

Real-world study of everolimus in advanced progressive neuroendocrine tumors

scientific article

Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer

scientific article published on January 2007

Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy

scientific article published on 27 February 2010

Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer

scientific article published on 26 January 2010

Reversible pancytopenia caused by oral letrozole assumption in a patient with recurrent breast cancer

scientific article published in September 2002

Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer

scientific article published on 30 April 2012

Risk of depressive events in long-term surviving patients affected by hormone-related cancer according to time after diagnosis

scientific article

Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial

scientific article

Should everolimus be stopped after radiological progression in metastatic insulinoma? A "cons" point of view

scientific article published on 02 June 2020

Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone

scientific article published on 10 April 2013

Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.

scientific article published on 29 April 2015

The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load.

scientific article published on 24 August 2006

The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma

scientific article published on 28 August 2020

The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers

scientific article published on 23 February 2011

The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen

scientific article

The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study.

scientific article published on 6 September 2012

Thrombotic thrombocytopenic purpura in advanced prostate cancer: case report and published work review

scientific article

Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors

scientific article published in February 2008

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design

scientific article published in October 2002

Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer

scientific article published on 21 April 2017

Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer

scientific article published on 14 September 2020

List of works by Alfredo Berruti

5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma

A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy.

Adjunctive treatment of adrenocortical carcinoma

Adjuvant bisphosphonates in patients with breast cancer: does the potency matter?

Adjuvant mitotane treatment for adrenocortical carcinoma

Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria

Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior

Androgen deprivation modulates gene expression profile along prostate cancer progression.

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients

Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study

Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy

Background to and management of treatment-related bone loss in prostate cancer.

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy

Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.

Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease.

Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma

Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

Combination chemotherapy in advanced adrenocortical carcinoma

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network

Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?

Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells

Decreasing Frequency of Osteonecrosis of the Jaw in Cancer and Myeloma Patients Treated with Bisphosphonates: The Experience of the Oncology Network of Piedmont and Aosta Valley (North-Western Italy) ⬇️

Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas

Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial

Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial

Excess of second tumors in denosumab-treated patients: a metabolic hypothesis

Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients

Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference.

Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

Gene expression profiling in breast cancer: a clinical perspective.

Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma

Human ASH-1 promotes neuroendocrine differentiation in androgen deprivation conditions and interferes with androgen responsiveness in prostate cancer cells.

Human ASH1 expression in prostate cancer with neuroendocrine differentiation

Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study

Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.

Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan

Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.

Magnetic resonance imaging in comparison to clinical palpation in assessing the response of breast cancer to epirubicin primary chemotherapy.

Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.

Metronomic therapy concepts in the management of adrenocortical carcinoma

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up

Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.

Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement.

Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma

Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer

Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions.

Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features ⬇️

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.

Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.

Real-world study of everolimus in advanced progressive neuroendocrine tumors

Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer

Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy

Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer

Reversible pancytopenia caused by oral letrozole assumption in a patient with recurrent breast cancer

Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer

Risk of depressive events in long-term surviving patients affected by hormone-related cancer according to time after diagnosis

Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial

Should everolimus be stopped after radiological progression in metastatic insulinoma? A "cons" point of view

Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone

Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects.

The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load.